Comparing two techniques for harvesting the left internal thoracic artery in heart surgery
Official title: Randomized Comparison of HARVesting the Left Internal Thoracic Artery in a Skeletonized Versus Pedicled Technique: the HARVITA Trial
Run by Medical University Innsbruck · NCT05931783 · Data updated 2026-11-12
This study is testing whether two different ways of taking the left internal thoracic artery for heart surgery can lead to better recovery and survival for people having coronary artery bypass surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 1350 (estimated) |
| Sponsor | Medical University Innsbruck Academic / other |
| Drugs / interventions | radiation |
| Locations | 8 sites (Graz and 7 other locations) |
| Status | Recruiting |
| Started | March 12, 2024 |
| Main results expected | October 1, 2028 |
| Study ends | October 1, 2031 |
| Registry record updated | March 15, 2024 |
| Trial ID | NCT05931783 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are primary isolated CABG patients with multi-vessel disease.
✕Probably not a fit
Patients over 80 years old or those requiring CABG without the use of LITA will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of two different techniques for harvesting the left internal thoracic artery (LITA) on graft patency rates and patient survival in individuals undergoing coronary artery bypass grafting (CABG). The study is a prospective, randomized, multi-centre trial that aims to determine whether the skeletonized or pedicled harvesting technique yields better clinical outcomes. By comparing these techniques, the trial seeks to provide evidence that could influence surgical practices and improve patient care in coronary artery disease. Participants will be carefully selected based on specific inclusion and exclusion criteria to ensure the validity of the results.
Why it matters
Potential benefit: If successful, this study could lead to improved graft patency rates and better survival outcomes for patients undergoing CABG.
How similar studies have gone: Other studies have explored similar harvesting techniques, but this trial aims to provide more definitive evidence on their comparative effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery). Exclusion criteria: * Age \> 80 years * Planned CABG without LITA use * Preoperative mediastinal radiation therapy * Emergency operation * Minimal invasive coronary artery bypass surgery * Any concomitant cardiac or non-cardiac procedures * Previous cardiac surgery * Known contrast agent allergy * Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome * Chronic kidney disease (GFR \<60ml/min/1.73m²) * Life expectancy of less than 5 years * Pregnancy * Hyperthyroidism * Iodine allergy Intraoperative exclusion criteria: * Y/T graft off the LITA graft * LITA sequential grafting * LITA target vessel other than LAD
Where it's running
-
Medical University of Innsbruck
Innsbruck, Austria Recruiting -
Medical University of Graz
Graz, Austria Not yet recruiting -
Medical University of Vienna
Vienna, Austria Not yet recruiting -
University of Duisburg-Essen
Essen, Germany Not yet recruiting -
University of Freiburg
Freiburg im Breisgau, Germany Not yet recruiting -
University Hospital Gießen
Giessen, Germany Not yet recruiting
Show 2 more locations
-
University of Jena
Jena, Germany Not yet recruiting -
University Hospital Bern
Bern, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Hannes Abfalterer, Dr. med. univ. — Medical University Innsbruck
- Study coordinator: Hannes Abfalterer, Dr. med. univ.
- Email: hannes.abfalterer@i-med.ac.at
- Phone: 004351250482988
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.